Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 67

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 67
---
 other actions taken in response to such hostilities
on the world economy and markets, have disrupted global markets and contributed to increased market volatility and uncertainty, which
could have an adverse impact on macroeconomic and other factors that affect our business and supply chain. Any disruption in our supply
chain could reduce our revenue and adversely impact our financial results. Such a disruption could occur as a result of any number of
events, including, but not limited to, military conflicts, geopolitical developments, war or terrorism, including the ongoing conflicts
in Ukraine and Israel and Gaza and disruptions in utility and other services. Any inability to obtain adequate deliveries or any other
circumstance that would require us to seek alternative sources of supply or to manufacture, assemble, and test such components internally
could significantly delay our ability to ship our products, which could damage relationships with current and prospective customers and
could harm our reputation and brand and could adversely affect our business, financial condition, and results of operations.

We
do not and cannot know if the ongoing conflicts and the economic sanctions imposed as a result of the conflicts, could escalate and result
in broader economic and security concerns which could adversely affect our business. It is not possible to predict the broader consequences
of these conflicts, which could include further sanctions, embargoes, regional instability, geopolitical shifts and adverse effects on
macroeconomic conditions, the availability and cost of materials, supplies, labor, currency exchange rates and financial markets, all
of which could have a material adverse effect on our business, financial condition and results of operations.

| 34 |

We are exposed to the risks of doing business internationally.

We
have in the past, and may in the future, operate outside of the United Kingdom. These international operations are subject to a number
of risks inherent in operating in different countries. These include, but are not limited to, risks regarding:

| • | currency exchange rate fluctuations; |

| • | restrictions on repatriation of earnings; |

| • | difficulty of effective enforcement of contractual provisions in local jurisdictions; |

| • | inadequate intellectual property (including confidentiality) protection in foreign countries; |

| • | public health epidemics or outbreaks, such as COVID-19; |

| • | trade-protection measures, import or export licensing requirements and fines, penalties or suspension or 
 revocation of export privileges; and                                                                     |

| • | changes in a specific country’s or a region’s political or economic conditions, including 
 the implications of the United Kingdom’s withdrawal from the European Union.